479 related articles for article (PubMed ID: 10517666)
21. Characterization of a corticotropin-releasing hormone-responsive element in the rat proopiomelanocortin gene promoter and molecular cloning of its binding protein.
Jin WD; Boutillier AL; Glucksman MJ; Salton SR; Loeffler JP; Roberts JL
Mol Endocrinol; 1994 Oct; 8(10):1377-88. PubMed ID: 7854355
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
23. Timing is critical for effective glucocorticoid receptor mediated repression of the cAMP-induced CRH gene.
van der Laan S; de Kloet ER; Meijer OC
PLoS One; 2009; 4(1):e4327. PubMed ID: 19177170
[TBL] [Abstract][Full Text] [Related]
24. Structural and functional conservation of vertebrate corticotropin-releasing factor genes: evidence for a critical role for a conserved cyclic AMP response element.
Yao M; Stenzel-Poore M; Denver RJ
Endocrinology; 2007 May; 148(5):2518-31. PubMed ID: 17289845
[TBL] [Abstract][Full Text] [Related]
25. The decidualizing effect of progesterone may involve direct transcriptional activation of corticotrophin-releasing hormone from human endometrial stromal cells.
Makrigiannakis A; Margioris AN; Chatzaki E; Zoumakis E; Chrousos GP; Gravanis A
Mol Hum Reprod; 1999 Sep; 5(9):789-96. PubMed ID: 10460215
[TBL] [Abstract][Full Text] [Related]
26. Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin promoter.
Morrison N; Eisman J
J Bone Miner Res; 1993 Aug; 8(8):969-75. PubMed ID: 8213259
[TBL] [Abstract][Full Text] [Related]
27. Phorbolester stimulates the activity of human corticotropin-releasing hormone gene promoter via 3',5'-cyclic adenosine monophosphate response element in transiently transfected chicken macrophages.
Van LP
Endocrinology; 1993 Jan; 132(1):30-4. PubMed ID: 8380380
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of a 3',5'-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter.
Spengler D; Rupprecht R; Van LP; Holsboer F
Mol Endocrinol; 1992 Nov; 6(11):1931-41. PubMed ID: 1480179
[TBL] [Abstract][Full Text] [Related]
29. Glucocorticoid repression of 3',5'-cyclic-adenosine monophosphate-dependent human corticotropin-releasing-hormone gene promoter activity in a transfected mouse anterior pituitary cell line.
Van LP; Spengler DH; Holsboer F
Endocrinology; 1990 Sep; 127(3):1412-8. PubMed ID: 1696884
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional regulation of hypothalamic corticotropin-releasing factor gene.
Kageyama K; Suda T
Vitam Horm; 2010; 82():301-17. PubMed ID: 20472145
[TBL] [Abstract][Full Text] [Related]
31. Functional analysis of glucocorticoid and insulin response sequences in the rat insulin-like growth factor-binding protein-1 promoter.
Goswami R; Lacson R; Yang E; Sam R; Unterman T
Endocrinology; 1994 Feb; 134(2):736-43. PubMed ID: 7507835
[TBL] [Abstract][Full Text] [Related]
32. Hormonal regulation of the c-fms proto-oncogene in breast cancer cells is mediated by a composite glucocorticoid response element.
Flick MB; Sapi E; Kacinski BM
J Cell Biochem; 2002; 85(1):10-23. PubMed ID: 11891846
[TBL] [Abstract][Full Text] [Related]
33. Complex regulatory interactions control CRH gene expression.
Nicholson RC; King BR; Smith R
Front Biosci; 2004 Jan; 9():32-9. PubMed ID: 14766341
[TBL] [Abstract][Full Text] [Related]
34. Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids.
Chen A; Perrin M; Brar B; Li C; Jamieson P; Digruccio M; Lewis K; Vale W
Mol Endocrinol; 2005 Feb; 19(2):441-58. PubMed ID: 15514029
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
[TBL] [Abstract][Full Text] [Related]
36. Regulation of steroidogenesis and the steroidogenic acute regulatory protein by a member of the cAMP response-element binding protein family.
Manna PR; Dyson MT; Eubank DW; Clark BJ; Lalli E; Sassone-Corsi P; Zeleznik AJ; Stocco DM
Mol Endocrinol; 2002 Jan; 16(1):184-99. PubMed ID: 11773448
[TBL] [Abstract][Full Text] [Related]
37. Pro-opiomelanocortin gene: a model for negative regulation of transcription by glucocorticoids.
Drouin J; Charron J; Gagner JP; Jeannotte L; Nemer M; Plante RK; Wrange O
J Cell Biochem; 1987 Dec; 35(4):293-304. PubMed ID: 3326882
[TBL] [Abstract][Full Text] [Related]
38. Contributions of distal and proximal promoter elements to glucocorticoid regulation of osteocalcin gene transcription.
Aslam F; Shalhoub V; van Wijnen AJ; Banerjee C; Bortell R; Shakoori AR; Litwack G; Stein JL; Stein GS; Lian JB
Mol Endocrinol; 1995 Jun; 9(6):679-90. PubMed ID: 8592514
[TBL] [Abstract][Full Text] [Related]
39. Cyclic adenosine-3',5'-monophosphate-mediated activation of a glutamine synthetase composite glucocorticoid response element.
Richardson J; Vinson C; Bodwell J
Mol Endocrinol; 1999 Apr; 13(4):546-54. PubMed ID: 10194761
[TBL] [Abstract][Full Text] [Related]
40. Reversal of glucocorticoids-dependent proopiomelanocortin gene inhibition by leukemia inhibitory factor.
Latchoumanin O; Mynard V; Devin-Leclerc J; Dugué MA; Bertagna X; Catelli MG
Endocrinology; 2007 Jan; 148(1):422-32. PubMed ID: 17038560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
